Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Saidi

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Clinical Medicine|December 11, 2025
Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe ObesityAlina N Saidi, Willy B Theel, Vivian D de Jong, et al.
Diabetes, Obesity & Metabolism|September 2, 2025
Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trialAlina N Saidi, Laura A M Konings, Carmen A W Dietvorst, et al.
Journal of Epidemiology and Global Health|August 3, 2022
Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020-January 2022John Otokoye Otshudiema, Gervais Léon T Folefack, Justus M Nsio, et al.
Plos One|May 18, 2023
Community-based COVID-19 active case finding and rapid response in the Democratic Republic of the Congo: Improving case detection and responseJohn Otokoye Otshudiema, Gervais Léon Tengomo Folefack, Justus M Nsio, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Clinical Medicine|December 11, 2025
Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe ObesityAlina N Saidi, Willy B Theel, Vivian D de Jong, et al.
Diabetes, Obesity & Metabolism|September 2, 2025
Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trialAlina N Saidi, Laura A M Konings, Carmen A W Dietvorst, et al.
Journal of Epidemiology and Global Health|August 3, 2022
Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020-January 2022John Otokoye Otshudiema, Gervais Léon T Folefack, Justus M Nsio, et al.
Plos One|May 18, 2023
Community-based COVID-19 active case finding and rapid response in the Democratic Republic of the Congo: Improving case detection and responseJohn Otokoye Otshudiema, Gervais Léon Tengomo Folefack, Justus M Nsio, et al.
Pageof 4